Safety and effectiveness of the fluocinolone acetonide intravitreal implant (ILUVIEN): 3-year results from the European IRISS registry study.

Isabella D Baur Tunde PetoFrank KochSimon R TaylorJoão Paulo Castro de SousaLauren HillClare BaileyUsha Chakravarthynull null

Published in: The British journal of ophthalmology (2022)

This study confirms the favourable, long-term benefit-to-risk profile of the FAc implant in eyes with cDMO, with an additional benefit in patients when this therapy is administered earlier.

Keyphrases

end stage renal disease
randomized controlled trial
systematic review

newly diagnosed
chronic kidney disease
optical coherence tomography

vascular endothelial growth factor
diabetic retinopathy
endothelial cells

patient reported outcomes
cell therapy
replacement therapy